Viewing Study NCT03699202


Ignite Creation Date: 2025-12-25 @ 4:01 AM
Ignite Modification Date: 2026-02-24 @ 4:13 AM
Study NCT ID: NCT03699202
Status: UNKNOWN
Last Update Posted: 2019-11-27
First Post: 2018-10-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti-RSV Study in Chinese Patients (ASCENT)
Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module